Skip to content
AnalystLens

AMETEK INC/ 8-K Report, Financial Results (Feb 4, 2025)

Reports
Earnings & Results·Other Events·Exhibits & Filings
Filing Date
Filed February 4, 2025
Period End
February 4, 2025
Security
AME
In the record · 2016–202610-K1110-Q328-K107

AME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 107 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · May ’16May ’16
  2. Material agreement8-K · Nov ’18Nov ’18
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Material agreement8-K · Jun ’26Jun ’26

01—Abstract

Summary

Summary of the 8-K filed February 4, 2025. Cited figures are marked; the original filing is the authoritative source.

AMETEK (NYSE: AME) reported record fourth-quarter 2024 results, with sales of $1.76 billiona (up 2% year over year), operating income of $469.0 million (up 5%), and an operating margin of 26.6%, up 90 basis points.

Adjusted diluted EPS rose 11% to $1.87b, while GAAP EPS was $1.67. Free cash flow reached a record $498.3 million, equal to 129% of net income. For full year 2024, sales grew 5% to $6.94 billion, adjusted EPS grew 7% to $6.83, and the company set annual records across sales, operating income, EBITDA, operating cash flow, free cash flow and EPS.

Results were pressured in the Electromechanical Group by normalizing OEM inventory levels, though management noted a second consecutive quarter of strong organic order growth there. Electronic Instruments posted record quarterly operating margin of 31.8%. For 2025, AMETEK guided to low-single-digit sales growth and adjusted EPS of $7.02 to $7.18c, representing 3% to 5% growth.

First-quarter sales are expected to be roughly flat year over year, with adjusted EPS of $1.67 to $1.69d. Management emphasized significant balance sheet capacity for acquisitions. The company also announced the acquisition of Kern Microtechnik, a German maker of ultra-precision machining and optical inspection systems with about EUR 50 million in annual sales, which will join the Electronic Instruments Group.

Balance sheet data show debt reduction, with short-term borrowings falling from $1.42 billion to $654 million and long-term debt falling from $1.90 billion to $1.43 billion year over year. The quarter's strong margin and cash flow performance supports AMETEK's long-term double-digit EPS growth objective. Investors will likely focus on whether the modest 2025 sales outlook reflects a cyclical trough in OEM demand, and on how the company deploys its substantial acquisition capacity.

02—Key points

Key Highlights

  1. Q4 2024 net sales were a record $1.76B (+2% YoY), with operating income up 5% to a record $469.0M and operating margin of 26.6% (+90 bps).
  2. Q4 adjusted diluted EPS was a record $1.87, up 11% YoY; GAAP EPS was $1.67.
  3. Free cash flow hit a record $498.3M in Q4, equal to 129% of net income; full-year operating cash flow was $1.83B (+5%).
  4. FY2024 sales grew 5% to $6.94B and adjusted EPS grew 7% to $6.83, with records set across most key metrics.
  5. Electronic Instruments Group posted a record 31.8% operating margin in Q4 (+280 bps), while Electromechanical Group sales rose 11% to $547M on Paragon Medical and A&D growth, offset by OEM inventory normalization.
  6. 2025 guidance calls for low-single-digit sales growth and adjusted EPS of $7.02–$7.18 (+3% to 5%); Q1 2025 sales are expected roughly flat with adjusted EPS of $1.67–$1.69.
  7. Announced acquisition of Kern Microtechnik (~EUR 50M sales) to join EIG's Ultra Precision Technologies division; debt declined meaningfully during 2024 (total debt down roughly $1.2B year over year).

03—Questions

Frequently Asked Questions

  1. How did AMETEK perform in the fourth quarter of 2024?

    AMETEK posted record quarterly sales of $1.76 billion, up 2%, and record operating income of $469.0 million, up 5%. Adjusted EPS was a record $1.87, up 11%, while GAAP EPS was $1.67. Free cash flow was a record $498.3 million.

  2. What is AMETEK's 2025 outlook?

    Management expects low-single-digit percentage sales growth for 2025 and adjusted EPS of $7.02 to $7.18, a 3% to 5% increase. For Q1 2025, sales are expected to be roughly flat year over year and adjusted EPS $1.67 to $1.69.

  3. Why did the Electromechanical Group's results look mixed?

    EMG sales rose 11% to $546.7 million, driven by the Paragon Medical acquisition and growth in Aerospace and Defense. However, EMG operating income was roughly flat at $111.2 million, and management cited normalizing inventory levels at OEM customers as a partial offset. Management also noted a second consecutive quarter of strong organic order growth.

  4. What is the Kern Microtechnik acquisition?

    AMETEK acquired Kern Microtechnik, a Munich-area manufacturer of ultra-precision machining and optical tool inspection systems with about EUR 50 million in annual sales. It will join the Electronic Instruments Group's Ultra Precision Technologies division, serving medical, semiconductor, research and space markets. The filing does not disclose the purchase price.

  5. How strong is AMETEK's balance sheet and cash generation?

    Full-year operating cash flow was $1.83 billion, up 5%. Short-term borrowings fell from $1.42 billion to $654 million, and long-term debt declined from $1.90 billion to $1.43 billion, while stockholders' equity rose to $9.66 billion. Management says the company has significant capacity to fund strategic acquisitions.

04—Continue

← View all 8-K filings